Earnings · China A-shares
ChengDa PharmaCeuticals Co., Ltd. Class A (301201) earnings
ChengDa PharmaCeuticals Co., Ltd. Class A published its Q3 report on 2026-10-27: net profit -174.09% year on year, -666.78% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved -4.71% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-27
- Period end
- 2026-09-30
- Net profit YoY
- -174.09%
- Excl. one-offs YoY
- -666.78%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -0.04% | — |
| 3 days | -4.71% | — |
| 7 days | +1.62% | — |
| 14 days | -9.62% | — |
Report history
Over the last 8 reports, net profit grew year on year in 2 of them. The stock rose in the 3 trading days after 1 of 6 reports (average -4.60%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-28 | -¥12.43M | -174.09% | — | +24.76% | -0.08 | -0.60% | -4.71% | — | — |
| 2026 interim report | 2026-08-26 | ¥2.30M | -82.07% | — | +40.03% | 0.02 | 0.11% | -7.64% | -25.37% | -18.37% |
| 2026 Q1 report | 2026-04-28 | ¥7.00M | +600.15% | +152.93% | +68.06% | 0.05 | 0.33% | +2.38% | -17.70% | -17.08% |
| 2025 annual report | 2026-04-28 | -¥11.93M | +57.56% | +53.72% | +21.99% | -0.08 | -0.56% | +2.38% | -17.70% | -17.08% |
| 2025 Q3 report | 2025-10-28 | ¥16.77M | -58.47% | -72.96% | +16.95% | 0.11 | 0.78% | -2.17% | +27.61% | +30.99% |
| 2025 interim report | 2025-08-26 | ¥12.82M | -49.06% | -8.37% | +11.24% | 0.08 | 0.60% | -9.29% | -5.56% | -7.24% |
| 2025 Q1 report | 2025-04-25 | -¥1.40M | -107.51% | — | -24.37% | -0.01 | -0.07% | -6.15% | +6.34% | +3.09% |
| 2024 annual report | 2025-04-25 | -¥28.10M | -130.89% | — | -19.59% | -0.18 | -1.29% | -6.15% | +6.34% | +3.09% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.